{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Fexofenadine Hydrochloride is an over-the-counter antihistamine tablet that helps relieve symptoms of indoor and outdoor allergies, such as runny nose, itchy eyes, and hives. Available in 60mg and 180mg strengths, it's taken orally and is non-drowsy. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Fexofenadine hcl \u2014 ANDA 211075 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211075", "mediaType": "text/html", "title": "Fexofenadine hcl"}], "identifier": "ANDA211075", "issued": "2016-09-16", "keyword": ["drug-manufacturers", "drug", "pharmaceuticals", "public-health", "drug-information"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Fexofenadine hcl"}